ARCHIVES

Trial Needed Of PSA To Determine Patients To Test, Chabner Says

This article is from The Cancer Letter archive.

Vol. 19 No. 10 | March 5, 1993

Download PDF Visit The Full Archive

Related Articles

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

April 2, 1999

Also von Eschenbach Role in Industry Program Raises New Concerns of Conflict of Interest.

November 22, 2006

NCI, FDA Courting Drug Sponsors To Add Clinical Trials To PDQ Database

October 11, 1996

New Therapies For Genitourinary Cancers In Clinical Testing Presented At ASCO

July 25, 2003

Substance From Sea Squirts In Phase II For Breast Cancer

November 29, 2002

Nimer to Lead Miami Sylvester Cancer Center

March 9, 2012